Mambou H, Pale S, Bopda O, Jugha V, Musa N, Ojongnkpot T
Front Pharmacol. 2025; 15:1301002.
PMID: 39996118
PMC: 11848678.
DOI: 10.3389/fphar.2024.1301002.
Park J, Kang M, Kim H, Hong H, Lee J, Song Y
Nat Commun. 2024; 15(1):10579.
PMID: 39632849
PMC: 11618371.
DOI: 10.1038/s41467-024-54803-z.
Zhu Z, McClintock T, Bieberich E
Genes Brain Behav. 2024; 23(4):e12911.
PMID: 39171374
PMC: 11339599.
DOI: 10.1111/gbb.12911.
Zhang H, Wang X
Cerebellum. 2024; 23(6):2575-2592.
PMID: 39052145
DOI: 10.1007/s12311-024-01722-w.
Tien T, Xu X, Song J, Zhang X, Zhang D, Yuan H
Physiol Res. 2024; 73(2):205-216.
PMID: 38710050
PMC: 11081185.
HD and SCA1: Tales from two 30-year journeys since gene discovery.
Thompson L, Orr H
Neuron. 2023; 111(22):3517-3530.
PMID: 37863037
PMC: 10842341.
DOI: 10.1016/j.neuron.2023.09.036.
Therapeutic Strategies for Spinocerebellar Ataxia Type 1.
Kerkhof L, van de Warrenburg B, van Roon-Mom W, Buijsen R
Biomolecules. 2023; 13(5).
PMID: 37238658
PMC: 10216181.
DOI: 10.3390/biom13050788.
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.
Coffin S, Durham M, Nitschke L, Xhako E, Brown A, Revelli J
Neuron. 2022; 111(4):481-492.e8.
PMID: 36577402
PMC: 9957872.
DOI: 10.1016/j.neuron.2022.11.016.
Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1.
Chen J, Chen S, Jin P, Sun S
Hum Genomics. 2022; 16(1):29.
PMID: 35906672
PMC: 9335979.
DOI: 10.1186/s40246-022-00404-0.
Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases.
Barbe L, Finkbeiner S
Front Aging Neurosci. 2022; 14:750629.
PMID: 35592702
PMC: 9110800.
DOI: 10.3389/fnagi.2022.750629.
Analysis of brain region-specific mRNA synthesis and stability by utilizing adult mouse brain slice culture.
Dzhala V, Fowler A, DiMarzio B, Staley K, Suh J
STAR Protoc. 2022; 3(2):101349.
PMID: 35509975
PMC: 9059153.
DOI: 10.1016/j.xpro.2022.101349.
Reduction of mutant ATXN1 rescues premature death in a conditional SCA1 mouse model.
Orengo J, Nitschke L, van der Heijden M, Ciaburri N, Orr H, Zoghbi H
JCI Insight. 2022; 7(8).
PMID: 35290244
PMC: 9089789.
DOI: 10.1172/jci.insight.154442.
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies.
McIntosh C, Li D, Wilton S, Aung-Htut M
Biomedicines. 2021; 9(11).
PMID: 34829728
PMC: 8615177.
DOI: 10.3390/biomedicines9111499.
N -Methyladenosine Modification in Chronic Stress Response Due to Social Hierarchy Positioning of Mice.
Guilherme M, Tsoutsouli T, Todorov H, Teifel S, Nguyen V, Gerber S
Front Cell Dev Biol. 2021; 9:705986.
PMID: 34490254
PMC: 8417747.
DOI: 10.3389/fcell.2021.705986.
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.
Cendelin J, Cvetanovic M, Gandelman M, Hirai H, Orr H, Pulst S
Cerebellum. 2021; 21(3):452-481.
PMID: 34378174
PMC: 9098367.
DOI: 10.1007/s12311-021-01311-1.
Partial deletion of chromosome 6p causing developmental delay and mild dysmorphisms in a child: molecular and developmental investigation and literature search.
Vrachnis N, Papoulidis I, Vrachnis D, Siomou E, Antonakopoulos N, Oikonomou S
Mol Cytogenet. 2021; 14(1):39.
PMID: 34303382
PMC: 8310580.
DOI: 10.1186/s13039-021-00557-y.
Precise CAG repeat contraction in a Huntington's Disease mouse model is enabled by gene editing with SpCas9-NG.
Oura S, Noda T, Morimura N, Hitoshi S, Nishimasu H, Nagai Y
Commun Biol. 2021; 4(1):771.
PMID: 34163001
PMC: 8222283.
DOI: 10.1038/s42003-021-02304-w.
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.
Zhang N, Bewick B, Schultz J, Tiwari A, Krencik R, Zhang A
Neurotherapeutics. 2021; 18(3):1710-1728.
PMID: 34160773
PMC: 8609077.
DOI: 10.1007/s13311-021-01075-w.
Dual targeting of brain region-specific kinases potentiates neurological rescue in Spinocerebellar ataxia type 1.
Lee W, Lavery L, Rousseaux M, Rutledge E, Jang Y, Wan Y
EMBO J. 2021; 40(7):e106106.
PMID: 33709453
PMC: 8013850.
DOI: 10.15252/embj.2020106106.
Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1.
Nitschke L, Coffin S, Xhako E, El-Najjar D, Orengo J, Alcala E
JCI Insight. 2021; 6(3).
PMID: 33554954
PMC: 7934855.
DOI: 10.1172/jci.insight.144955.